HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (24) Citing Articles via Google Scholar Google Scholar Articles by Ansarin, K. Articles by Chapman, K.R. Search for Related Content PubMed PubMed Citation Articles by Ansarin, K. Articles by Chapman, K.R.

Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function

¹ Asthma Centre of the University Health Network, Toronto, Ontario, Canada and ² Dept of Medicine, Division of Respiratory Medicine, University of Toronto, Toronto, Ontario, Canada

CORRESPONDENCE: K.R. Chapman, Suite 4-011 ECW, 399 Bathurst Street, Toronto, Ontario, Canada. Fax: 1 4166033456

Keywords: asthma, chronic obstructive pulmonary disease, diffusion capacity, forced expiratory volume in one second, nitric oxide

The following study was undertaken in order to determine how exhaled nitric oxide (eNO) levels in former smokers with chronic obstructive pulmonary disease (COPD) compared to eNO levels in patients with asthma and in healthy nonsmoking volunteers. The study also aimed to determine any relationship between eNO levels in COPD and: 1) conventional measures of lung function; and 2) inhaled corticosteroid (ICS) use.

In former smokers with COPD, nonsmokers with asthma and volunteers, eNO levels, spirometry, lung volumes, carbon monoxide diffusion capacity of the lung (D_L,CO) and resting oxygen saturation (S_a,O2) were measured.

Median eNO was significantly higher among patients with COPD than among healthy volunteers (p=0.003) but lower than among patients with asthma (p<0.01). There was no significant difference in eNO levels between COPD patients using ICS and those not using ICS. By contrast, eNO was lower among asthma patients who used ICS (median 32 parts per billion (ppb); 25–75% range 16–54) than among asthma patients who did not (51 ppb; 32–87) (p=0.034). Among patients with COPD, eNO was inversely correlated with forced expiratory volume in one second, D_L,CO and S_a,O2, and was positively correlated with the residual lung volume/total lung capacity ratio. Among patients with asthma, no significant correlations were found.

Exhaled nitric oxide is increased in patients with chronic obstructive pulmonary disease, an increase that is influenced by structural abnormalities of tobacco-induced lung damage.